14 March 2022
Nasal Covid-19 vaccine based on Abera’s technology shows good results in study from Johns Hopkins University School of Medicine and VU (Molecular Microbiology)
A collaboration between researchers at Johns Hopkins University School of Medicine (Baltimore, USA; PI’s Ken Witwer and Jason Villano) and Vrije Universiteit (Molecular Microbiology; PI Joen Luirink) has generated a novel SARS-CoV-2 vaccine candidate. Read the whole article here.